Product Information
ESCITALOPRAM 15 MG CAPSULE is a generic product labeled by Almatica Pharma LLC, priced at $5.4532 per EA under NDC 52427079530. Its NADAC has been published 33 times since Feb 18, 2026.
FDA first approved this application on Aug 29, 2025.
The High Outlier badge above means this manufacturer's average price in the escitalopram market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
15 mg/1
Manufacturer
Almatica Pharma LLCNDC
52427079530
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ESCITALOPRAM OXALATEApproval Type
New Drug (NDA)
FDA Application
NDA219130FDA Approved
8/29/2025
On Market Since
10/6/2025
Pharmacological Classes
Price Statistics
The NADAC for ESCITALOPRAM 15 MG CAPSULE has been published 33 times since Feb 18, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.4532 per EA |
|---|---|
| All-time high | $5.4532 (Sep 30, 2026) |
| All-time low | $5.4075 (Aug 19, 2026) |
| 52-week high | $5.4532 |
| 52-week low | $5.4075 |
| Median price | $5.4193 |
| Average price | $5.4203 |
| Largest weekly change | +0.8% (Sep 23, 2026) |
| Weeks tracked | 33 |
| Tracking since | Feb 18, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the escitalopram market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Almatica Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
escitalopram market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ESCITALOPRAM 15 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 15 MG CAPSULE, manufactured by Almatica Pharma LLC, is $5.4532 per EA (NDC 52427079530), effective Sep 30, 2026.
How has the price of ESCITALOPRAM 15 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ESCITALOPRAM 15 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 33 weekly CMS publications since Feb 18, 2026.
What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 15 MG CAPSULE?
Since Feb 18, 2026, the NADAC for ESCITALOPRAM 15 MG CAPSULE has ranged from a low of $5.4075 (Aug 19, 2026) to a high of $5.4532 (Sep 30, 2026), with a median of $5.4193 per EA.
Are there cheaper alternatives to ESCITALOPRAM 15 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of ESCITALOPRAM 15 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ESCITALOPRAM 15 MG CAPSULE?
ESCITALOPRAM 15 MG CAPSULE (NDC 52427079530) is labeled by Almatica Pharma LLC, and CMS classifies it as a generic product.